GAMMA Investing LLC grew its holdings in National Health Investors, Inc. (NYSE:NHI - Free Report) by 8,469.9% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 13,369 shares of the real estate investment trust's stock after acquiring an additional 13,213 shares during the quarter. GAMMA Investing LLC's holdings in National Health Investors were worth $987,000 at the end of the most recent reporting period.
Other hedge funds have also made changes to their positions in the company. Norges Bank acquired a new stake in shares of National Health Investors in the fourth quarter valued at approximately $42,322,000. Millennium Management LLC lifted its holdings in shares of National Health Investors by 1,967.0% in the 4th quarter. Millennium Management LLC now owns 488,353 shares of the real estate investment trust's stock valued at $33,843,000 after buying an additional 464,727 shares during the period. Balyasny Asset Management L.P. purchased a new position in National Health Investors in the 4th quarter valued at approximately $23,917,000. Marshall Wace LLP increased its position in National Health Investors by 161.6% during the fourth quarter. Marshall Wace LLP now owns 551,585 shares of the real estate investment trust's stock worth $38,225,000 after buying an additional 340,712 shares in the last quarter. Finally, Land & Buildings Investment Management LLC increased its position in National Health Investors by 109.4% during the fourth quarter. Land & Buildings Investment Management LLC now owns 467,056 shares of the real estate investment trust's stock worth $32,367,000 after buying an additional 243,999 shares in the last quarter. Hedge funds and other institutional investors own 62.51% of the company's stock.
Analyst Upgrades and Downgrades
Several equities research analysts have commented on the company. Wedbush restated an "outperform" rating and set a $88.00 price target on shares of National Health Investors in a research note on Monday, March 17th. Truist Financial boosted their price objective on National Health Investors from $76.00 to $77.00 and gave the company a "hold" rating in a research report on Monday, June 9th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. According to data from MarketBeat.com, National Health Investors has a consensus rating of "Hold" and a consensus price target of $85.75.
Read Our Latest Research Report on NHI
National Health Investors Stock Down 1.4%
NHI opened at $69.91 on Tuesday. National Health Investors, Inc. has a one year low of $65.13 and a one year high of $86.13. The company has a debt-to-equity ratio of 0.92, a quick ratio of 10.29 and a current ratio of 10.29. The stock's fifty day moving average is $73.77 and its 200-day moving average is $71.85. The company has a market capitalization of $3.26 billion, a PE ratio of 24.02, a P/E/G ratio of 4.42 and a beta of 0.75.
National Health Investors (NYSE:NHI - Get Free Report) last announced its earnings results on Monday, May 5th. The real estate investment trust reported $1.15 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.13 by $0.02. National Health Investors had a return on equity of 10.11% and a net margin of 38.53%. The company had revenue of $68.87 million for the quarter, compared to analyst estimates of $85.13 million. During the same period in the previous year, the firm earned $1.10 earnings per share. National Health Investors's revenue for the quarter was up 9.6% compared to the same quarter last year. On average, equities analysts predict that National Health Investors, Inc. will post 4.41 EPS for the current fiscal year.
National Health Investors Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, August 1st. Shareholders of record on Monday, June 30th will be paid a $0.90 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.60 dividend on an annualized basis and a yield of 5.15%. National Health Investors's dividend payout ratio (DPR) is currently 114.29%.
About National Health Investors
(
Free Report)
Incorporated in 1991, National Health Investors, Inc NYSE: NHI is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider National Health Investors, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Health Investors wasn't on the list.
While National Health Investors currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
